DrugSafety News

DrugSafety News From AOL News

Opinion: The FDA's Battle With Bogus Drug Claims

(Nov. 23) - We've all sat in front of the TV listening to an earnest-looking man in a white coat confiding in us that the new drug he holds will save – or at least markedly improve – our lives. In the back of our minds, we recalled something about government agencies protecting us from false advertising. When...

DrugSafety News From AOL

THE HUFFINGTON POST

Tafamidis: FDA Shoots Down Drug For Familial Amyloid Polyneuropathy

U.S. drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease.

AOL MONEY & FINANCE

FDA advisers recommend approving weight loss drug

WASHINGTON -Advisers to government health regulators have recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks.

DrugSafety News From the Web

05/26/12 D.C. Week: FDA User Fee Bill Gets Senate OK Source: Revolution Health In a rare instance of bipartisanship, a bill to reauthorize FDA user fee programs sailed through the Senate, and an FDA advisory committee voted against adding an acute coronary syndrome indication to rivaroxaban (Xarelto).
05/25/12 Senate inches closer to passage of FDA reauthorization... Source: News-Medical.Net The Senate struck a deal to vote Thursday afternoon on 17 amendments before moving onto final passage of the bill to reauthorize the Food and Drug Administration's user fee programs.
05/25/12 Congress votes down Sen. Durbin's anti-supplement... Source: NaturalNews.com (NaturalNews) A sneaky, eleventh-hour attempt by Senator Dick Durbin (D-Ill.) to essentially shut down the supplement industry alongside an amendment pertaining to prescription drug user fees has failed.
05/24/12 Agency Information Collection Activities; Submission... Source: PharmCast.com SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
05/24/12 Medigus receives FDA approval for reflux endoscope Source: Globes Medigus Ltd. (TASE: MDGS ) has received US Food and Drug Administration (FDA) approval for its SRS endoscope for minimally invasive treatment of gastroesophageal reflux disease (GERD), and will launch marketing in the US immediately.